Steris (STE) Cash from Investing Activities (2018 - 2026)
Steris (STE) posted Cash from Investing Activities of -$108.5 million for Q2 2026, up 50.05% on a QoQ basis from -$217.2 million in Q1 2026, and little changed year-over-year from -$108.5 million in Q2 2025.
Analysis
Steris (STE) Cash from Investing Activities (2018 - 2026) Analysis & Trends
Steris has reported Cash from Investing Activities for 9 years, with the latest figure at -$108.5 million in Q2 2026.
- On a quarterly basis, Cash from Investing Activities changed 0.0% year-over-year to -$108.5 million in Q2 2026; TTM through Jun 2026 was -$512.5 million, a 25.77% decrease from a year earlier, with the FY2026 full-year figure at -$512.5 million, down 231.82% from the prior year.
- Cash from Investing Activities was -$108.5 million for Q2 2026 at Steris, up from -$217.2 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $687.8 million in Q2 2024, with the low at -$606.2 million in Q3 2023.
- Average Cash from Investing Activities over 5 years is -$78.3 million, with a median of -$98.5 million recorded in 2022.
- The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities slumped 519.08% in 2023, then surged 1132.79% in 2024.
- Over 5 years, Cash from Investing Activities stood at -$98.4 million in 2022, then decreased by 20.84% to -$118.9 million in 2023, then declined by 4.19% to -$123.9 million in 2024, then climbed by 20.5% to -$98.5 million in 2025, then decreased by 10.15% to -$108.5 million in 2026.
- The last three Cash from Investing Activities figures came in at -$108.5 million (Q2 2026), -$217.2 million (Q1 2026), and -$98.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -26.60 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -1.62 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | -639.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | -1.96 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -193.20 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 329.80 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | -190.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -108.50 Mn |
| Mar 31, 2026 | -217.20 Mn |
| Dec 31, 2025 | -98.50 Mn |
| Sep 30, 2025 | -88.30 Mn |
| Jun 30, 2025 | -108.50 Mn |
| Mar 31, 2025 | -69.80 Mn |
| Dec 31, 2024 | -123.90 Mn |
| Sep 30, 2024 | -105.30 Mn |
| Jun 30, 2024 | 687.80 Mn |
| Mar 31, 2024 | -95.65 Mn |
| Dec 31, 2023 | -118.92 Mn |
| Sep 30, 2023 | -606.24 Mn |
| Jun 30, 2023 | -66.60 Mn |
| Mar 31, 2023 | -77.58 Mn |
| Dec 31, 2022 | -98.41 Mn |
| Sep 30, 2022 | -97.93 Mn |
| Jun 30, 2022 | -109.42 Mn |
| Mar 31, 2022 | 93.58 Mn |
| Dec 31, 2021 | -79.80 Mn |
| Sep 30, 2021 | -76.80 Mn |